Safety of SNK01 in Subjects With Alzheimer's Disease (ASK-AD)

NCT04678453 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated after completing the dose escalation portion of the study. The expansion cohort was not initiated to conduct a global trial based on the approved US IND using a new manufacturing process.

Conditions

Interventions

Sponsor

NKGen Biotech, Inc.